» Articles » PMID: 36680273

African Swine Fever Virus Infection and Cytokine Response In Vivo: An Update

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Jan 21
PMID 36680273
Authors
Affiliations
Soon will be listed here.
Abstract

African swine fever (ASF) is a hemorrhagic viral disease of domestic pigs and wild suids (all ) caused by the ASF virus (ASFV). The disease is spreading worldwide without control, threatening pig production due to the absence of licensed vaccine or commercially available treatments. A thorough understanding of the immunopathogenic mechanisms behind ASFV infection is required to better fight the disease. Cytokines are small, non-structural proteins, which play a crucial role in many aspects of the immune responses to viruses, including ASFV. Infection with virulent ASFV isolates often results in exacerbated immune responses, with increased levels of serum pro-inflammatory interleukins (IL-1α, IL-1β, IL-6), TNF and chemokines (CCL2, CCL5, CXCL10). Increased levels of IL-1, IL-6 and TNF are often detected in several tissues during acute ASFV infections and associated with lymphoid depletion, hemorrhages and oedemas. IL-1Ra is frequently released during ASFV infection to block further IL-1 activity, with its implication in ASFV immunopathology having been suggested. Increased levels of IFN-α and of the anti-inflammatory IL-10 seem to be negatively correlated with animal survival, whereas some correlation between virus-specific IFN-γ-producing cells and protection has been suggested in different studies where different vaccine candidates were tested, although future works should elucidate whether IFN-γ release by specific cell types is related to protection or disease development.

Citing Articles

A Mutant of Africa Swine Fever Virus Protein p72 Enhances Antibody Production and Regulates the Production of Cytokines.

Li M, Wang Y, Wang Q, Yang L, Liu S, Li G Viruses. 2025; 17(2).

PMID: 40006949 PMC: 11860850. DOI: 10.3390/v17020194.


Gene Editing for Enhanced Swine Production: Current Advances and Prospects.

Ju W, Kim S, Lee J, Lee H, No J, Lee S Animals (Basel). 2025; 15(3).

PMID: 39943192 PMC: 11815767. DOI: 10.3390/ani15030422.


Progress in African Swine Fever Vector Vaccine Development.

Yang Y, Yuan H, Zhang Y, Luan J, Wang H Int J Mol Sci. 2025; 26(3).

PMID: 39940691 PMC: 11816837. DOI: 10.3390/ijms26030921.


Insights and progress on epidemic characteristics, pathogenesis, and preventive measures of African swine fever virus: A review.

Li M, Zheng H Virulence. 2025; 16(1):2457949.

PMID: 39937724 PMC: 11901552. DOI: 10.1080/21505594.2025.2457949.


Replication Characteristics of African Swine Fever Virus (ASFV) Genotype I E70 and ASFV Genotype II Belgium 2018/1 in Perivenous Macrophages Using Established Vein Explant Model.

Han S, Oh D, Balmelle N, Cay A, Ren X, Droesbeke B Viruses. 2024; 16(10).

PMID: 39459935 PMC: 11512260. DOI: 10.3390/v16101602.


References
1.
Zhang F, Wang H, Wang X, Jiang G, Liu H, Zhang G . TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget. 2016; 7(32):52294-52306. PMC: 5239552. DOI: 10.18632/oncotarget.10561. View

2.
Dawson H, Sang Y, Lunney J . Porcine cytokines, chemokines and growth factors: 2019 update. Res Vet Sci. 2020; 131:266-300. DOI: 10.1016/j.rvsc.2020.04.022. View

3.
Alonso C, Borca M, Dixon L, Revilla Y, Rodriguez F, Escribano J . ICTV Virus Taxonomy Profile: Asfarviridae. J Gen Virol. 2018; 99(5):613-614. DOI: 10.1099/jgv.0.001049. View

4.
Bleul C, Fuhlbrigge R, Casasnovas J, Aiuti A, Springer T . A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996; 184(3):1101-9. PMC: 2192798. DOI: 10.1084/jem.184.3.1101. View

5.
Arango Duque G, Descoteaux A . Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014; 5:491. PMC: 4188125. DOI: 10.3389/fimmu.2014.00491. View